C. Woodard

发表

Phase II trial of sequential chemotherapy followed by chemoradiation, surgery, and postoperative chemotherapy for the treatment of stage IIIA/IIIB non-small-cell lung cancer.

S. Ou, B. Halmos, A. Muzikansky, 2006, Clinical lung cancer.

137 A phase I study of an oral vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitor, CP-547,632, in patients with advanced solid tumors

A. Tolcher, D. Noe, D. Healey, 2004 .